Corporate
2023.04.19
First subject for LT3001 Phase 2 trial enrolled in China
Finance
2023.03.20
Lumosa team to attend STAIR XII
Corporate
2023.03.07
Lumosa Therapeutics Announces an Out-License Agreement with Pakistan’s AJM Pharma for LT1001
Corporate
2023.02.10
Lumosa Attending the 2023 International Stroke Conference
Finance
2022.11.04
Lumosa will participate in the "Biotech Forum" sponsored by Masterlink Securities
Corporate
2022.11.01
Lumosa Exhibiting at CPhI Frankfurt 2022